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IL-25/IL-17E is a member of the structurally re-
lated IL-17 cytokine family (1). The cardinal 
family member is IL-17 (IL-17A), which is a 
proinfl  ammatory cytokine derived from T cells 
with specifi  c roles in allergic and humoral re-
sponses (2) that has been found to be elevated in 
diseases such as asthma (3), rheumatoid arthritis 
(4), multiple sclerosis (5), and systemic lupus ery-
thematosus (6), as well as in transplant rejection 
(7). Human IL-17A is secreted as a homodimeric 
glycoprotein. Initial cloning of IL-17A cDNA 
identifi  ed signifi  cant sequence homology with 
an open reading frame of Herpes saimiri (8). More 
recently, database searches and degenerative 
RT-PCR strategies have identifi  ed fi  ve related 
cytokines (IL-17B, IL-17C, IL-17D, IL-17E/
IL-25, and IL-17F) that share between 16 and 
50% sequence homology with IL-17A (9, 10).
Although the biological functions of the 
various IL-17 family members remain to be 
fully characterized, studies have suggested that 
IL-17A, IL-17B, and IL-17C have several co-
incident biological activities typical of type 1 
infl  ammatory responses. In contrast, studies of 
IL-17E (IL-25) have indicated that its functions 
are signifi  cantly diff  erent from the other fam-
ily members and are associated with type 2 re-
sponses. Indeed, transgenic expression of both 
human IL-25 (11) and mouse IL-25 (12) has 
been shown to induce type 2 biased responses 
with increased IL-4, IL-5, IL-13 produc-
tion, eosinophilia, and elevated IgE. Similarly, 
  administration of recombinant mouse IL-25 
(rIL-25) also induced Th2 pathologies that 
were shown to be dependent on the down-
stream production of the Th2 cytokines IL-4, 
IL-5 and IL-13 (13). Native IL-25 expression 
has been detected from in vitro–diff  erentiated 
Th2 cells (13) and in vitro–cultured mast cells 
(14). However, identifi   cation of the IL-25–
  responsive cell populations has proven elusive, 
although a non–B/non–T (NBNT) cell popu-
lation expressing high levels of MHC class II 
and low levels of CD11c has been reported to 
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up-regulate IL-5 and IL-13 production after stimulation with 
IL-25 (13).
Type 2 responses are characteristic of the benefi  cial 
  immune responses generated to combat parasitic helminth 
infection, but also of the inappropriate immune response 
leading to allergy and asthma. Within this response, the 
CD4+ Th2 cell subset-producing cytokines that include IL-
4, IL-5, IL-9, and IL-13 play a central role in the regulation 
of eff  ector functions such as stimulating B cell growth and 
initiating immunoglobulin isotype switching to IgE, and 
  inducing goblet cell hyperplasia and associated mucus pro-
duction, eosinophilia, mastocytosis, and fi  brosis (15). It is also 
evident that cells of the innate immune system, including eo-
sinophils, basophils, and mast cells, can also produce signifi  -
cant levels of IL-4, IL-5, IL-9, and IL-13 that can alter the 
magnitude of the type 2 response, both by providing appro-
priate signals at the initiation of a response, as well as sustain-
ing ongoing type 2 responses (15–17). Indeed, it has been 
reported recently that polarized type 2 responses, induced 
  after infection with the parasitic helminth Nippostrongylus 
brasiliensis, develop independently of the adaptive immune 
response with innate cells representing an important initial 
source of IL-4 to drive Th2 diff  erentiation (18, 19). Basophils 
have been shown to be a principal source of IL-4 during 
N. brasiliensis infection (20) and in response to T-  independent 
antigen challenge (21).
The role of IL-25 in protective immunity is currently 
undefi  ned. To investigate how IL-25 might regulate type 2 
cytokine responses, we generated a novel line of il25−/− mice 
and assessed their immune responses to helminth infection. 
Signifi   cantly, in the absence of IL-25, mice fail to expel 
N. brasiliensis effi   ciently. This defect correlates with a striking 
delay in the up-regulation of type 2 cytokine production. This 
does not appear to be the result of an inability to generate 
Th2 cells per se, but correlates with a defi  cit in a population 
of NBNT, c-kit+, FcεR1−, IL-4–, IL-5–, IL-13–producing 
cells in the draining lymph nodes of the infected il25−/− mice 
after parasite infection.
RESULTS
il25−/− mice fail to expel N. brasiliensis effi  ciently 
and have delayed type 2 cytokine production
Gastrointestinal helminth parasites typically induce a type 2 
phenotype (22). N. brasiliensis is a commonly used parasite 
model and disruption of type 2 cytokines has been shown to 
compromise effi   cient parasite clearance (15). To determine a 
possible role for IL-25 in protective type 2 responses, we 
generated il25−/− mice (Fig. S1, available at http://www.
jem.org/cgi/content/full/jem.20051615/DC1). We infected 
il25−/− mice and wild-type controls with N. brasiliensis and 
monitored for worm burden and type 2 eff  ector functions. 
The wild-type and il25−/− mice displayed very similar worm 
burdens at day 5 after infection; by day 10 after infection, the 
wild-type animals had expelled their parasites, whereas the 
il25−/− mice retained an extremely high worm burden 
(Fig. 1 A). Even at 15 d after infection, the il25−/− mice still 
harbored signifi  cant numbers of intestinal parasites. Further-
more, measurement of N. brasiliensis egg production from the 
infected groups demonstrated that, before expulsion, the worms 
were healthy and fecund (Fig. 1 B).
We assessed antigen-specifi  c cytokine production from 
the mesenteric lymph node (MLN) cells of the infected 
il25−/− and wild-type mice. As expected, wild-type animals 
produced elevated levels of IL-5 and IL-13 in response to 
infection as determined by N. brasiliensis antigen restimula-
tion of MLN cells isolated at day 5 after infection (Fig. 1 C). 
In contrast, cytokine production from the il25−/− mice at 
the same time point revealed IL-5 and IL-13 levels approx-
imately fi  vefold lower than wild-type controls (Fig. 1 C). 
By day 10 after infection, when the wild-type animals had 
  already expelled their parasite burden, the levels of IL-5 and 
IL-13 had fallen relative to day 5 levels. These data contrast 
with the highly up-regulated IL-4, IL-5, and IL-13 secretion 
detected at day 10 after infection in il25−/− mice, at a time 
when viable egg-laying worms remained in the intestine. 
Such elevated levels of type 2 cytokines are indicative of 
com  pensatory cytokine production arising from the sustained 
antigenic stimulation as a result of the temporal delay in 
the il25−/− mice expelling their parasite burden (Fig. 1 C). 
With the decreasing parasitic load observed at days 15 and 
20 after infection, the levels of type 2 cytokines declined 
  substantially (Fig. 1 C).
Type 2 cytokines induce a spectrum of eff  ector func-
tions that have been demonstrated to play central roles in 
the regulation of helminth infections, including eosinophilia, 
immunoglobulin isotype switching to IgE and IgG1, masto-
cytosis, goblet cell hyperplasia, and fi  brosis (15, 22). Serum 
samples collected from wild-type and il25−/− mice at various 
time points after infection were analyzed for the presence of 
total serum IgE. At days 0 and 5, comparable levels of IgE 
were detected in the serum of wild-type and il25−/− mice; 
however, after day 10 of infection more highly elevated IgE 
production was detected in the serum of il25−/− mice (Fig. 
1 D). This correlates with the increased expression of IL-4, 
a key switch factor for IgE production in the mouse (15). 
A similar overexpression was also detected for mast cell pro-
tease-1, used as a measure of mast cells, in the serum from 
il25−/− mice 10–20 d after infection (Fig. 1 E). Surprisingly, 
given the central role for mucus production in worm ex-
pulsion and the importance of IL-13 in inducing this eff  ec-
tor function, we were unable to detect any signifi  cant delay 
in the onset of goblet cell hyperplasia (Fig. 1 F). There was 
also no diff  erence between wild-type and il25−/− mice in 
the marked elevation in blood basophils (NBNT, c-kit−, 
FcεR1+, SSClow; Fig. 1 G) that occurs during N.   brasiliensis 
infection (16, 23, 24). However, using fl  ow cytometric anal-
ysis of the blood isolated from animals after infection, we 
observed a defi  cit in the number of circulating eosinophils 
(NBNT, CCR3+, SSChigh) in il25−/− mice at day 10, but not 
at day 5 after infection (Fig. 1 H). These data indicate that, 
with the exception of eosinophils, the main type 2 eff  ector 
functions in the il25−/− mice are either normal or elevated JEM VOL. 203, April 17, 2006  1107
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at day 10 after infection with N. brasiliensis and that this up-
regulation correlates with the continued presence of worms 
in these animals at this time point. However, given the defi  cit 
in Th2 cytokines observed at day 5 in the il25−/− mice, it is 
probable that a combination of subtle changes in the onset 
of IL-4–, IL-5–, and IL-13–induced eff  ector functions may 
explain the initial failure to expel the intestinal worms eff  ec-
tively. Equally, it is also possible that IL-25 could alter worm 
expulsion by a Th2-cytokine–independent pathway such as 
altering intestinal muscle contractility as has been demon-
strated for IL-13 (25).
Administration of rIL-25 induces rapid worm expulsion that 
is T and B cell independent but type-2 cytokine dependent
To confi  rm a role for IL-25 in parasite worm expulsion, 
N. brasiliensis–infected wild-type and il25−/− mice were treated 
with exogenous rIL-25. rIL-25 induced a potent infl  amma-
tory response in the intestines of all treated mice, indepen-
dent of helminth infection (unpublished data). Signifi  cantly, 
the intraperitoneal administration of rIL-25 caused extremely 
rapid N. brasiliensis expulsion from both experimental groups, 
with no worms present in the intestines of treated mice even 
at the 5 d time point (Fig. 2 A). Control animals injected 
Figure 1.  il25−/− mice fail to expel N. brasiliensis efficiently 
and have delayed type 2 cytokine production. (A) Infected mice 
were killed at the times indicated to obtain intestinal worm counts. 
(B) Fecal egg counts were determined at the times indicated. Epg, 
eggs per gram of feces. (C) Cytokine production after infection. 
MLN cells from wild-type and il25−/− animals after infection with 
N. brasiliensis were stimulated with N. brasiliensis antigen. Cytokines 
were analyzed by ELISA. (D) Total serum IgE expression from wild-
type and il25−/− animals after infection. (E) Mouse mast cell 
protease-1 (MMCP-1) activity was measured from sera. (F) Determi-
nation of goblet cell number and enumeration of PAS positive goblet 
cells per villus crypt unit. (G) Blood basophils were enumerated after 
FACS analysis of NBNT, c-kit−, FcεR1+, SSClow cells. (H) Blood eosino-
phils were enumerated after FACS analysis of NBNT, CCR3+, SSChigh. 
White bars, wild type; black bars, il25−/−. Cohorts of five to six 
  infected mice were used per group. Data are presented as means plus 
standard error and are representative of two to three experiments. 
ND, not detected.1108  IL-25–DEPENDENT TYPE 2 IMMUNITY | Fallon et al.
with vehicle solution contained worm numbers consistent 
with successful infection (Fig. 2 A). To confi  rm that, after 
IL-25 treatment, the N. brasiliensis larvae were not retained 
abnormally in the lungs and were able to migrate to the in-
testine, worm counts were made in these tissues from days 1 
to 5. Worm counts in the lungs and intestine confi  rmed nor-
mal migration and infection levels in both the treated and un-
treated animals before the more rapid expulsion of the worms 
from the IL-25–treated mice on day 5 (Fig. S2, available  at  
http://www.jem.org/cgi/content/full/jem.20051615/DC1). 
Thus, rIL-25 can accelerate worm expulsion and   reverse the 
phenotype of the il25−/− mice.
Although we had failed to fi  nd a critical requirement for 
IL-25 in T cell diff  erentiation to Th2 cells in vitro (Fig. 
S3, available at http://www.jem.org/cgi/content/full/
jem.20051615/DC1), in agreement with a report that treat-
ment of T cells with IL-25 does not alter Th2 cytokine secre-
tion (13), it remained possible that the IL-25 was mediating 
worm expulsion by directly or indirectly activating T cells. 
We therefore infected rag1−/− mice with N. brasiliensis to de-
termine whether this expulsion was mediated via NBNT cells 
and administered them with rIL-25 or vehicle. As expected, 
rag1−/− failed to expel worms even 10 d after infection (Fig. 
2 B). In contrast, treatment of rag1−/− mice with rIL-25 re-
sulted in highly accelerated worm expulsion with only a few 
worms surviving in the intestine at day 5 after infection.
We next assessed whether helminth expulsion was medi-
ated directly by IL-25 or by the downstream induction of the 
classical type 2 cytokines (IL-4, IL-5, IL-9, and IL-13) and 
their subsequent initiation of type 2 eff  ector functions. We 
have shown previously that il4−/−il5−/−il9−/−il13−/− mice 
exhibit a severe delay in worm expulsion as a result of their 
inability to initiate type 2 eff  ector functions. We infected 
il4−/−il5−/−il9−/−il13−/− mice with N. brasiliensis, treated 
them with either rIL-25 or vehicle, and assessed worm burden. 
In complete contrast with wild-type mice treated with rIL-
25, the intestines of il4−/−il5−/−il9−/−il13−/− mice treated 
with rIL-25 and infected with N. brasiliensis appeared macro-
scopically normal (unpublished data) and contained high 
numbers of worms even 10 d after infection (Fig. 2 C). These 
results demonstrate that IL-25 mediates its eff  ects by regulat-
ing the production of at least one of the classical type 2 cyto-
kines, leading to helminth expulsion.
Collectively, these data demonstrate that T cells, or indeed 
B cells, are not obligatory for N. brasiliensis expulsion after 
rIL-25 treatment and suggest that IL-25 can induce a potent 
type 2 cytokine response from NBNT cells capable of elimi-
nating parasite infection even in the absence of T cell help.
Infection with N. brasiliensis induces a novel population 
of NBNT, c-kit+, Fc𝗆R1− cells that is dependent on IL-25
Recent reports have indicated that NBNT cells (initially 
identifi  ed as eosinophils, and subsequently as basophils and 
putative mast cell/basophil precursors) in the lungs of N. 
brasiliensis–infected mice play key roles in innate immunity to 
helminth infection by secreting type 2 cytokines, including 
IL-4 and IL-5 (18, 19). Furthermore, Fort et al. reported that 
IL-25 induces cytokine production by a NBNT population, 
although they were unable to identify the specifi  c cell popu-
lation involved (13).
We therefore used fl   ow cytometry to determine the 
  composition of NBNT cells in the draining MLN, which is 
the site of diff  erential cytokine activity in infected mice (Fig. 
1 C), of wild-type and il25−/− mice 5 and 10 d after infection. 
In wild-type mice, infection stimulates an increase in CD19−, 
CD4−, CD8− (NBNT), c-kit+, FcεR1− cells in the MLN 
(Fig. 3 A). In contrast, no increase in this cell population 
was detected in MLN from il25−/− mice 5 d after infection 
Figure 2.  Administration of rIL-25 induces rapid worm expulsion 
that is independent of T and B cells, but dependent on type 2 cyto-
kine production. Cohorts of mice (n = 3–5 per group) were infected 
with N. brasiliensis in the presence or absence of rIL-25 and killed on days 
5 or 10 to obtain intestinal worm counts. Data are presented as means 
plus standard error and are representative of two to three experiments. 
ND, not detected. (A) Wild-type and il25−/− mice. (B) Wild-type and 
rag1−/− mice. (C) Wild-type and il4−/−il5−/−il9−/−il13−/− mice.JEM VOL. 203, April 17, 2006  1109
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(Fig. 3 A). Furthermore, this defi  ciency was specifi  c to the 
MLN, as we were unable to detect diff  erences in any of these 
populations in blood or cell suspensions derived from in-
fected lungs and spleen isolated from infected wild-type or 
il25−/− mice 5 and 10 d after infection (unpublished data). 
Uninfected  il25−/− mice had similar frequencies to these 
NBNT, c-kit+ FcεR1− cells as wild-type mice (Fig. 3 A). 
These results indicate that, in the absence of IL-25, a popula-
tion of NBNT, c-kit+, FcεR1− cells either fails to develop 
normally in the lymph node or fails to migrate effi   ciently to 
this site during the innate response to worm infection.
To confi  rm that the NBNT, c-kit+, FcεR1− cell pop-
ulation was induced by IL-25, we administered rIL-25 to 
wild-type mice and used fl  ow cytometry to determine the 
composition of NBNT cell populations in the MLN and 
spleen 4 d afterward. Treatment with rIL-25 resulted in an 
increase in the population of NBNT, c-kit+, FcεR1− cells in 
MLN, but not in the spleen (Fig. 3 B). We also confi  rmed that, 
using rag1−/− animals, the NBNT, c-kit+, FcεR1− cells do 
not require T or B cells for their induction in the MLN after 
rIL-25 administration (Fig. 3 C). Furthermore, administra-
tion of rIL-25 continued to induce the appearance of NBNT, 
c-kit+, FcεR1− cells in the MLN of il4−/−il5−/−il9−/−il13−/− 
mice (Fig. 3 D). Indeed, we observed substantially greater 
numbers of these cells in the il4−/−il5−/−il9−/−il13−/− mice, 
possibly indicating a role for the type 2 cytokines in traffi   ck-
ing or diff  erentiation of these precursors. These data indicate 
that rIL-25 treatment induces NBNT, c-kit+, FcεR1− cells 
independently of T and B cells and the type 2 cytokines.
NBNT, c-kit+, Fc𝗆R1− cells induced by N. brasiliensis 
infection or administration of rIL-25 produce IL-4, IL-5, 
and IL-13
Our data suggest the requirement for a type 2 cytokine–
  secreting NBNT cell in mediating N. brasiliensis expulsion. We 
therefore purifi  ed the NBNT, c-kit+, FcεR1− cells using 
fl  ow cytometry from mice either infected with N. brasiliensis 
or treated with rIL-25 and used PCR analysis to determine 
their cytokine expression. Signifi  cantly, the NBNT, c-kit+, 
FcεR1− cells purifi  ed from MLN 4 d after rIL-25 treatment 
expressed mRNA encoding the classical type 2 cytokines 
IL-4, IL-5, and IL-13 (Fig. 4 A). A similar profi  le was also 
detected 5 d after infection with N. brasiliensis (Fig. 4 B).
To complement the expression data obtained from cells 
purifi  ed by fl  ow cytometry, we also used 4get mice, in which 
IL-4 expression is linked to egfp (26), to determine the fre-
quency of IL-4–producing NBNT, c-kit+, FcεR1− cells in 
the MLN of mice administrated with rIL-25. Using this ap-
proach, we confi  rmed that the NBNT, c-kit+, FcεR1− cell 
subpopulation induced by rIL-25 was primed as an IL-4–
  producing cell type (Fig. 4 C). We also determined the frequency 
of IL-4–producing NBNT, c-kit+, FcεR1− cells in the MLN 
of uninfected 4get mice and 4get animals infected for 5 and 
10 d with N. brasiliensis. N. brasiliensis infection evoked a sub-
stantial induction of IL-4–producing NBNT, c-kit+, FcεR1− 
cells in the MLN by day 5 of infection (Fig. 4 D).
Figure 3.  IL-25 induces NBNT, c-kit+, Fc𝗆R1− cell population in 
the MLN. (A) NBNT, c-kit+, FcεR1− cells are defi  cient in the MLN of 
il25−/− animals 5 d after infection with N. brasiliensis (Nb). Cohorts of 
wild-type and il25−/−-infected mice (n = 5–6) were killed and the NBNT, 
c-kit+, FcεR1− cell population assessed by fl  ow cytometry. (B) BALB/c 
mice (n = 3–5) were administered with rIL-25 and fl  ow cytometry was 
used to analyze NBNT, c-kit+, FcεR1− cells in the MLN and spleen 4 d 
later. (C) Cohorts of wild-type and rag1−/− mice (n = 3–5) were adminis-
tered with rIL-25 and fl  ow cytometry used to analyze NBNT, c-kit+, 
FcεR1− cells in the MLN 4 d later. (D) Cohorts of wild-type and il4−/−il5−/−
il9−/−il13−/− mice (n = 3–5) were administered with rIL-25 and fl  ow 
cytometry used to analyze NBNT, c-kit+, FcεR1− cells in the MLN 4 d later. 
Data are representative of two to three experiments.1110  IL-25–DEPENDENT TYPE 2 IMMUNITY | Fallon et al.
The 4get mice also allowed us to assess the relative pro-
portions of IL-4–producing CD4+ T cells and IL-4– producing 
NBNT, c-kit+, FcεR1− cells in the MLN at 5 and 10 d after 
infection. It is noteworthy that the onset of the IL-4–producing 
NBNT, c-kit+, FcεR1− cells precedes the major expansion 
of IL-4–producing CD4+ T cells (Fig. 4 E). IL-4–producing 
NBNT, c-kit+, FcεR1− cells increase approximately two- to 
threefold in number, rising to 4–5 × 103 per MLN 5 d after 
infection (Fig. 4 F), making up almost 30% of the NBNT, 
c-kit+, FcεR1− population (not depicted). In contrast, we 
  detected no change in the number of IL-4–producing 
CD4+ T cells at day 5 after infection (Fig. 4 G), although by 
day 10 of infection, IL-4–producing CD4+ T cells had 
  increased dramatically.
Several studies have evaluated the functional importance 
of eosinophils, basophils, and mast cells in providing an early 
source of type 2 cytokines. Histological analysis of cytospins 
of FACS-purifi   ed NBNT, c-kit+, FcεR1− cells showed 
them to be small agranular cells with limited cytoplasm 
(Fig. 5 A). Flow cytometric analysis using several lineage markers 
was undertaken to further defi  ne the NBNT, c-kit+, FcεR1− 
cells. The cell surface marker analysis of the NBNT, c-kit+, 
FcεR1− cells precluded their defi  nition as mature eosino-
phils, basophils, or mast cells (Fig. 5 B). Furthermore, cell 
surface phenotyping also precluded their defi  nition as NK 
cells (Fig. 5 B). Similar staining profi  les were also obtained 
with NBNT, c-kit+, FcεR1− cells from N. brasiliensis–
  infected mice (unpublished data). To further defi  ne  their 
  lineage, mRNA was prepared from NBNT, c-kit+, FcεR1− 
cells purifi  ed from animals that were administered rIL-25 and 
subjected to gene expression analysis using a panel of eosino-
phil, basophil, and mast cell genes (Fig. 5 C). Our data dem-
onstrate that these cells do not express cell surface markers or 
lineage-specifi  c genes that are characteristic of mature eosin-
ophils, mast cells, or basophils. Furthermore, preliminary 
  microarray data indicate an absence of eosinophil, basophil, 
mast cell, neutrophil, and NK-specifi  c genes in the mRNA 
isolated from the NBNT, c-kit+, FcεR1− cells (unpublished 
data). This suggests that the NBNT, c-kit+, FcεR1− cells 
represent a novel cell population and may represent a precur-
sor population.
IL-25 induces type 2 cytokine production from c-kit+ MLN 
cells in vitro
It has been shown previously that IL-25 can induce produc-
tion of IL-5 and IL-13 in vitro, primarily from an NBNT 
subset (13). We wished to determine if NBNT, c-kit+, 
Figure 4.  NBNT, c-kit+, Fc𝗆R1− cells induced by IL-25 in vivo 
produce IL-4, IL-5, and IL-13. (A) After administration of IL-25, NBNT, 
c-kit+, FcεR1− cells were purifi  ed using fl  ow cytometry and the expres-
sion of il4, il5, and il13 determined using Taqman real-time PCR. Mast, 
PMA/ionomycin-activated, bone marrow–derived mast cells. NBNT, c-kit+, 
FcεR1− sorted cells. Th1, splenocytes stimulated under Th1 cell differen-
tiation conditions for 48 h. (B) After N. brasiliensis infection NBNT, c-kit+ 
cells were purifi  ed using fl  ow cytometry and the expression of il4, il5, and 
il13 was determined using Taqman real-time PCR. Mast, PMA/ionomycin-
activated, bone marrow–derived mast cells. NBNT, NBNT, c-kit+ sorted 
cells. Th1, splenocytes stimulated under Th1 cell differentiation conditions 
for 48 h. (C) 4get mice were administered with rIL-25 and the frequency 
of GFP+ NBNT, c-kit+, FcεR1− cells was analyzed by fl  ow cytometry. 
(D) 4get mice were infected with N. brasiliensis (Nb) and the   frequency of 
GFP+ NBNT, c-kit+ cells was analyzed by fl  ow cytometry at the time 
points indicated. (E) 4get mice were infected with N. brasiliensis and the 
frequency of GFP+ CD4+ cells was analyzed by fl  ow cytometry at the time 
points indicated. (F) Numbers of GFP+, NBNT, c-kit+, FcεR1− cells in MLN 
after infection. (G) Numbers of GFP+, CD4+ cells in MLN after infection 
are shown.JEM VOL. 203, April 17, 2006  1111
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FcεR1− cells isolated from naive animals and stimulated in 
vitro with rIL-25 could be induced to express type 2 cyto-
kines. Using fl  ow cytometry, we purifi  ed NBNT, c-kit+, 
FcεR1− cells from the MLN and spleen of naive mice. The 
cells were treated in vitro with rIL-25 for 4 d and cytokine 
expression was analyzed. We found that the NBNT, c-kit+, 
FcεR1− cells isolated from the MLN, but not the spleen, 
produced highly elevated levels of IL-5 and IL-13 after stim-
ulation with IL-25 (Fig. 6, A and B). We were unable to 
  detect IL-5 or IL-13 expression after IL-25 stimulation of 
NBNT cells purifi  ed from the bone marrow of naive mice 
(Fig. 6 C). Thus, the NBNT, c-kit+, FcεR1− MLN cell 
population that arises in response to IL-25 represents a potent 
source of type 2 cytokines that are initiated early in the im-
mune response to intestinal parasite infection. It is notewor-
thy that IL-4 protein was below the levels of detection using 
ELISA and ELISPOT (unpublished data) in these cultures, 
although we cannot preclude that it is secreted, but is being 
used by the cells and removed from the medium.
To assess whether NBNT, c-kit+, FcεR1− MLN cells 
could enhance type 2 cytokine production from activated 
T cells, we cocultured NBNT, c-kit+, FcεR1− MLN cells 
purifi  ed by fl  ow cytometry from rIL-25–treated il13−/− mice 
with highly purifi  ed T cells from untreated wild-type mice 
in the presence or absence of exogenous IL-25. In this way, 
we could determine whether coculture increased IL-13 ex-
pression from the wild-type T cells in the absence of back-
ground IL-13 production from the il13−/− NBNT, c-kit+, 
FcεR1− MLN cells. In repeat experiments, we observed a 
modest increase in the ability of T cells cocultured with 
NBNT, c-kit+, FcεR1− MLN cells in the presence of IL-25 
to produce IL-13 when IL-25 was added (Fig. 6, D and E). 
It is noteworthy that NBNT, c-kit−, FcεR1− MLN cells 
also induced elevated levels of IL-13 production from T cells 
after addition of IL-25, and can still produce type 2 cyto-
kines when purifi  ed from wild-type mice (unpublished data). 
These data indicate that the NBNT population contains 
more than one IL-25-responsive cell type that we have yet 
to identify, or that c-kit is transiently expressed on the 
IL-25–responsive population. However, we did not observe 
an increase in the proportions of NBNT, c-kit−, FcεR1− 
MLN cells in response to either N. brasiliensis infection or 
treatment of mice with rIL-25 in vivo. Future studies will be 
required to elucidate the role of these additional IL-25 
  responsive cells.
DISCUSSION
Our studies have highlighted the importance of IL-25 in the 
rapid and robust generation of the type 2 response required 
for the expulsion of N. brasiliensis from the intestine. Although 
type 2 responses are essential for the clearance of N. brasilien-
sis, only IL-13 has been shown to be critical for expulsion 
(27, 28). However, the analysis of compound type 2 cyto-
kine-defi  cient mice has uncovered redundant functions of 
IL-4, IL-5, IL-9, and IL-13 in the process of worm expulsion 
(15). In the absence of IL-25, we found that antigen-driven 
Figure 5.  Analysis of purifi  ed NBNT, c-kit+, Fc𝗆R1− cells from IL-25–
treated wild-type mice. (A) NBNT, c-kit+, FcεR1− cells were isolated 
by cell sorting and cytospin preparations of sorted cells stained with 
  Giemsa or Toludine. (B) Flow cytometry of cell surface marker expression. 
(C) Analysis of gene expression. neg, no template control; mast, bone 
marrow–derived mast cells; c-kit+, NBNT, c-kit+, FcεR1− cells; Th2, spleno-
cytes stimulated under Th2 cell differentiation conditions for 48 h; pos, 
image clone used as positive control; CCR, chemokine receptor; MCP, 
mast cell protease; EPO, eosinophil peroxidase. EPO positive control was 
IMAGE clone 30044595. CCR1 positive control was IMAGE clone 3992755.1112  IL-25–DEPENDENT TYPE 2 IMMUNITY | Fallon et al.
Th2 cytokine production was impaired 5 d after N. brasiliensis 
infection, with reduced levels of IL-5 and IL-13, and this 
  correlated with the inability to expel the parasite. Surprisingly, 
given this defi  cit in type 2 cytokines, we did not detect any 
reduction in goblet cells, mast cells, or IgE in the il25−/− ani-
mals after infection. However, we did observe a signifi  cant 
delay in eosinophilia in the il25−/− mice. Although eosino-
phils alone have not been shown to be essential for N. brasil-
iensis expulsion, they are highly up-regulated after infection 
and have been reported to play roles in protection against 
helminth infection (15, 22, 29). We believe that it is likely 
that the signifi  cant reduction in eosinophils probably occurs 
alongside more minor defi  cits in the other type 2 eff  ector 
functions, which we were unable to detect, leading to the 
observed phenotype.
Our results also indicate the striking potency of IL-25 
in inducing worm expulsion, even in the absence of T cells. 
Thus, although T cells are normally required for worm ex-
pulsion, treatment with exogenous IL-25 is able to substitute 
for these cells. The mechanism of worm clearance is clearly 
dependent on type 2 cytokines and likely results from the 
highly accentuated type 2 eff  ector functions that are observed 
after administration of IL-25, including infl  ammation  and 
mucus production (references 13, 30 and unpublished data). 
Interestingly, given the potent biological eff  ects of IL-25, 
we have found that mRNA-encoding IL-25 is expressed at 
very low levels in the intestine as reported previously (30). 
Further studies will be necessary to identify the mechanism of 
cellular activation and the cell sources of IL-25 production 
after infection.
Despite the pronounced eff  ect of il25 disruption on the 
production of Th2 cytokines, we were unable to detect any 
role for IL-25 in the direct regulation of Th2 cell diff  eren-
tiation or cytokine production in vitro (Fig. S3). This is in 
agreement with the fi  ndings of Fort et al., who, despite ob-
serving increased expression of type 2 cytokines after admin-
istration of IL-25, were unable to uncover any direct role for 
IL-25 for the growth or diff  erentiation of T helper cells (13). 
However, a possible role for IL-25 in regulating type 2 cyto-
kine production by NBNT cells has been proposed (13). We 
identifi  ed a reproducible decrease in the frequency of NBNT, 
c-kit+, FcεR1− cells in MLN isolated from il25−/− mice 5 d 
after infection. Signifi   cantly, administration of rIL-25 re-
versed this defi  cit and induced an elevation in the NBNT, 
c-kit+, FcεR1− cell population in the MLN that exceeded that 
observed even after N. brasiliensis infection. The expansion of 
the NBNT, c-kit+, FcεR1− cytokine-producing cells after 
infection was clearly distinguishable from elevations previ-
ously described in basophils (NBNT, c-kit−, FcεR1+) and 
eosinophils (NBNT, CCR3+, SSChigh) (16, 18–21, 23, 24).
The expression of type 2 cytokines from cells of the in-
nate immune system, including eosinophils, basophils, and 
mast cells, has also been implicated in the onset of immune 
responses to N. brasiliensis. Basophils (NBNT, c-kit−, FcεR1+) 
are known to be signifi  cant IL-4 producers in response to N. 
brasiliensis infection (16, 24). We determined that the NBNT, 
c-kit+, FcεR1− cell population represented an early potential 
source of IL-4, IL-5, and IL-13. IL-4 is a key cytokine in the 
regulation of Th2 cell diff  erentiation, and cellular sources of 
early IL-4 production are believed to play critical roles in 
Figure 6.  IL-25 induces type-2 cytokine production from NBNT, 
c-kit+, Fc𝗆R1− MLN cells in vitro. (A) NBNT, c-kit+, FcεR1− cells from 
the MLN of naive mice were purifi  ed by fl  ow cytometry and treated in 
vitro with rIL-25 for 4 d and cytokine expression was analyzed by ELISA. 
(B) NBNT, c-kit+, FcεR1− cells from the spleens of naive mice were puri-
fi  ed by fl  ow cytometry and treated in vitro with rIL-25 for 4 d and cyto-
kine expression was analyzed by ELISA. (C) NBNT cells were purified 
from bone marrow and treated in vitro with rIL-25 for 4 d and cytokine 
expression analyzed by ELISA. ND, not detected. (D and E) NBNT, c-kit+, 
FcεR1− cells were purifi  ed from rIL-25–treated il13−/− mice and cultured 
in triplicate with highly purifi  ed wild-type CD3+ cells, on anti-CD3–
coated plates, in the presence or absence of IL-25. D and E are two inde-
pendent experiments. Differences in IL-13 production between untreated 
and IL-25–treated cells were analyzed using Student’s t test.JEM VOL. 203, April 17, 2006  1113
ARTICLE
controlling the effi   ciency of the type 2 response (19, 31, 32). 
Furthermore, both IL-5 and IL-13 are known to alter the 
magnitude of the type 2 response, as well as sustaining ongo-
ing type 2 responses, through their induction of type 2 eff  ec-
tor functions (15). Our results are consistent with a role for 
an NBNT, c-kit+, FcεR1− cell population in enhancing 
Th2 polarization, but we have been unable to detect IL-4 at 
the protein level and it remains uncertain if the IL-4 mRNA 
is translated and if IL-4 is secreted. Furthermore, because our 
data do not directly demonstrate a functional role for the 
NBNT, c-kit+, FcεR1− cell population in mediating IL-25–
dependent host protection, it remains possible that IL-25 
could work through other cells/mechanisms to infl  uence the 
type 2 response. Indeed, we have observed that further 
NBNT, c-kit− cell subsets can respond to IL-25 by secreting 
IL-13. Thus, although we only observed the expansion of the 
NBNT, c-kit+, FcεR1− cell population, it is possible that 
IL-25 may also aff  ect the function, rather than the expansion, 
of several other cell populations that may also contribute to 
resistance. It is also clear that, even in the absence of IL-25, 
a defi   nitive Th2-cytokine response is eventually induced 
(though with slower kinetics), indicating that alternative 
pathways exist that can compensate for a defi  ciency in IL-25. 
Such functional redundancy is a common feature of   cytokine-
regulated systems, and several cellular sources of early IL-4 
production have been reported, including T cells (33, 34), 
NK cells (35), mast cells and basophils (19, 24, 36, 37), and 
eosinophils (18, 19). A further possibility is that in vivo IL-25 
may be able to act directly on T cells, thereby enhancing 
type 2 cytokine production, and that we and previous inves-
tigators have been unable to recapitulate the conditions re-
quired for this activity in vitro (13).
It is possible that these MLN NBNT, c-kit+, FcεR1−, 
type 2 cytokine–producing cells correspond to similar c-kit+ 
cells identifi  ed in the lungs of N. brasiliensis–infected IL-4/GFP 
reporter mice (19), although in this study we have not de-
tected these cells in the lung. It was speculated (19) that this 
c-kit+ lung cell population is a possible common basophil/
mast cell precursor as described previously in the human 
  system (38). Indeed, the IL-25–dependent NBNT, c-kit+, 
FcεR1−, type 2 cytokine–producing cells that we show in 
the MLN of N. brasiliensis–infected mice may be previously 
described, but functionally uncharacterized c-kit+ mast cell–
committed progenitor cell that has also been reported after 
N. brasiliensis infection (39). Despite characterizing the ex-
pression of a panel of eosinophil, mast cell, and basophil genes, 
we have been unable to defi  ne the NBNT, c-kit+, FcεR1−, 
type 2 cytokine–producing cells as belonging to a specifi  c 
lineage, suggesting that they may represent a novel lineage or 
a precursor cell population.
The reduced frequency of NBNT, c-kit+, FcεR1−, 
type 2 cytokine–producing cells in the MLN of the il25−/− 
mice after infection may result from a failure of these cells 
to migrate to the draining lymph node or it may be the re-
sult of ineffi   cient expansion or diff  erentiation of this popu-
lation in situ. Although IL-25 has not been demonstrated 
to have direct growth factor activity on mouse T and B cells 
(11), spleens from IL-25–treated mice have been reported 
to contain signifi  cantly elevated numbers of hematopoietic 
progenitor cells, though the mechanism for this remains 
undefi  ned (13). A role for IL-25 in regulating cell migra-
tion has also been suggested by its ability to stimulate 
  expression of the chemokines IL-8 (10) and GROα (12) 
and the adhesion molecules ICAM-1 and VCAM-1 (12). 
However, in vitro assays have failed to demonstrate eosino-
phil chemoattractant activity for IL-25 (30). Further studies 
will be necessary to determine the origin of these cells in 
the lymph node.
This is the fi  rst report of the functional importance of 
IL-25 in the immune response to the intestinal parasite 
N. brasiliensis. Our results clearly demonstrate that IL-25 is an 
important early regulatory molecule in the genesis of type 2 
immunity. IL-25 regulates innate type 2 immune cells whose 
cytokine expression precedes the subsequent induction of 
known adaptive Th2 cell–mediated immunity.
MATERIALS AND METHODS
Mice. BALB/c mice were obtained from Harlan UK and maintained in the 
SABU/CBS facilities or in Trinity College, Dublin, in specifi  c pathogen-
free environments. 4get (26) and rag1−/− (40) mice, on a BALB/c back-
ground, were purchased from Jackson ImmunoResearch Laboratories and 
bred in Trinity College, Dublin or in SABU/CBS facilities. il4−/−il5−/−
il9−/−il13−/− mice on a BALB/c background were as described previously 
(15). il25−/− mice were generated and maintained as described in supple-
mental Materials and methods (available at http://www.jem.org/cgi/content/
full/jem.20051615/DC1). All animal experiments outlined in this report were 
undertaken with the approval of the UK Home Offi   ce or the Department 
of Health and Children, Ireland.
Helminth infection. Individual mice were inoculated subcutaneously with 
500 viable third-stage N. brasiliensis larvae. Animals were killed 5, 10, 15, and 
20 d after infection, the intestinal worm burdens were determined, and 
  serum was taken. N. brasiliensis–infected mice treated with PBS or IL-25 
(see IL-25 administration and assay) were killed on days 2–5 after infection 
and lung and intestinal worm counts were determined. For lung counts, the 
lungs were removed, chopped fi  nely with scissors, and incubated for 3 h at 
37°C in saline. Emergent larvae were counted using a dissecting microscope. 
Feces were collected for fecal egg counts. Jejunal tissue was removed and 
processed for histology as described previously (41). In addition, MLN cells 
were harvested, counted, and analyzed by fl  ow cytometry or stimulated in 
vitro at either 2.5 × 106 cells/ ml with plate-bound anti-CD3 or at 5 × 106 
cells/ml with 50 μg/ml of parasite antigens (NbES) (42) for 72 h. Super-
natants were harvested and analyzed for cytokines. Lungs were removed and 
chopped before digestion in 1 mg/ml collagenase D (Roche Diagnostics 
GmbH) in RPMI 1640 with FCS for 30 min at 37°C with gentle shaking. 
Lung digests were fi  ltered through 100-μm Falcon cell strainers (Becton 
Dickinson) followed by three washes and further fi  ltering through 40-μm 
cell strainers before analysis by fl  ow cytometry. For isolation of blood granu-
locytes, mice were exsanguinated by cardiac puncture. Blood was collected 
on ice over citrate-phosphate-dextrose solution (1.4:10; Sigma-Aldrich) and 
centrifuged immediately. Plasma was removed and red blood cells were lysed 
by two rounds of exposure to ammonium chloride.
IL-25 administration and assay. 0.4 μg of rIL-25 (R&D Systems) in PBS 
was administered per mouse intraperitoneally on days 0–4 for N. brasiliensis 
infections. Mice were culled on day 5 and tissues were harvested for analysis. 
For rIL-25 treatment alone, mice were administered 0.4 μg of rIL-25 (R&D 
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on days 0–3; mice were culled on day 4 and tissues were harvested for analy-
sis. Control animals received PBS only.
NBNT, c-kit−, FcεR1− and NBNT, c-kit+, FcεR1− cells were sorted 
from naive MLN or spleen and plated at 105 cells/well. rIL-25 was added 
at 10 ng/ml and the cells were incubated for 4 d. Cytokine production was 
assessed by ELISA.
Harvest of NBNT from bone marrow. Bone marrow was fl  ushed asep-
tically from femora and tibias of 8-wk-old mice. The cell suspension was 
  incubated with biotin-conjugated anti-CD4, -CD8, and -CD19 (eBioscience) 
then M280 streptavidin Dynabeads (Dynal) were used to remove labeled 
cells according to the manufacturer’s instructions.
Flow cytometry. Cell surface marker expression was assessed by fl  ow cyto-
metry using a FACScan fl  ow cytometer (Becton Dickinson). The following 
mAbs were used: Tri-color conjugated anti-CD19 (6D5; Caltag), Tri-color 
conjugated anti-CD4 (CT-CD4; Caltag); Tri-color conjugated anti-CD8a 
(5H10; Caltag); PE-conjugated anti-CCR-3 (83101.111; BD Biosciences); 
FITC-conjugated anti-FcεR1 (MAR-1; eBioscience); PE-conjugated 
CD117 (c-kit; ACK45; BD Biosciences); Gr-1 (RB6-8C5; BD Biosciences); 
CD11b (M1/70; BD Biosciences); CD11c (HL3; BD Biosciences); B220 
(RA36B2; BD Biosciences), MHCII (14–4-45; BD Biosciences); CD80 (16-
10A1; BD Biosciences); CD86 (GL1; BD Biosciences); Thy1.2 (30-H-12; 
BD Biosciences); CD34 (RAM34; BD Biosciences); and DX5 (eBioscience). 
Gates were set using isotype control antibodies. Cells were counted and resus-
pended in ice-cold FACS buff  er (2% FCS, 0.05% sodium azide in PBS) at 
2 × 106 cells/ml on a 96-well plate. Cells were stained with surface antibodies 
for 30 min on ice and washed three times in FACS buff  er.
NBNT cells were gated as cells negative for CD19, CD4, and CD8 
(reference 18). Blood eosinophils were identifi   ed as NBNT, CCR-3+, 
SSChigh, whereas blood basophils were NBNT, c-kit−, FcεR1+, SSClow. 
IL-4–expressing cells in 4get mice were detected in the FL1 channel on cells 
surface stained as described in the previous paragraph.
Cell sorting was used to isolate the NBNT, c-kit+, SSClow cells from 
single cell suspensions of the MLN or spleen. Cells were stained with 
Tri-color–conjugated anti-CD4, CD8, and CD19; PE or allophycocyanin-
conjugated anti-CD117 (c-kit); and sorted on a FACSAria (Conway Insti-
tute) or MoFlo cell sorter (MRC-LMB, Cambridge). In some experiments, 
biotin-conjugated anti-FcεR1 was also included to exclude mature mast 
cells. The sorted cells were >97% pure.
In vitro T helper cell diff  erentiation assays. MLN cells or splenocytes 
were cultured on anti-CD3 antibody-coated plates (1 μg/ml of clone 2C11; 
Becton Dickinson) in the presence of exogenous cytokines or anti-cytokine 
antibody as indicated. 10 ng/ml IL-2 (R&D Systems) was added to all cul-
tures. Th2 cell diff  erentiation was promoted in the presence of 100 ng/ml 
IL-4 (R&D Systems) and anti-IFNγ antibody (10 μg/ml of clone XMG1.2; 
Becton Dickinson), whereas Th1 diff  erentiation was promoted by anti–IL-4 
antibody at 10 μg/ml (clone 11B11; DNAX Research Institute) and 1 ng/ml 
IL-12 (Genzyme). Cells were cultured for 5 d, washed, and resuspended at 
106 cells/ml for 24 h in the presence of plate-bound anti-CD3. Supernatants 
were analyzed by cytokine ELISA. In some cases, cells were harvested after 
48 h for mRNA preparation.
Mast cells and RNA preparation. Bone marrow was aseptically fl  ushed 
from femora and tibias of 8-wk-old mice. The cell suspension was cultured 
at 4 × 105 cells/ml in the presence of 5 ng/ml of IL-3 and 10% WEHI-3B 
conditioned supernatant for 3–4 wk, with media changes every 7 d. The re-
sultant cell populations were 95% c-kit+ and Gr-1+ when analyzed by fl  ow 
cytometry (BD Biosciences). After washing, cells were resuspended at 
106 cells/ml and stimulated for 1 h with the polyclonal activators PMA at 
50 ng/ml and/or calcium ionophore A23187 at 500 ng/ml.
NBNT cell/T cell coculture. NBNT, c-kit−, FcεR1− and NBNT, 
c-kit+, FcεR1− cells were sorted from MLN of IL-13–defi  cient mice after 
treatment with IL-25 (see IL-25 administration and assay). NBNT, c-kit−, 
FcεR1−, and NBNT, c-kit+, FcεR1− cells were cocultured on anti-CD3–
coated (145-2C11; BD Biosciences) plates (0.3 μg/ml), with CD3+ cells 
purifi  ed from untreated wild-type spleens by cell sorting using PE- conjugated 
anti-CD3 (145-2C11; BD Biosciences) (CD3+ cells were >97% pure). 
Where indicated, IL-25 was added to the cultures at a concentration of 
10 ng/ml. The cells were cocultured for 72 h before the supernatant was 
harvested and assessed for the presence of IL-13 using the Quantikine 
  Murine IL-13 Kit (R&D Systems).
Real-time PCR. Real-time PCR was performed for IL-13 using TaqMan-
labeled probe chemistry and using a FAM-labeled probe to enable the detec-
tion of amplifi  ed product as it accumulates during PCR (Table S1, available 
at http://www.jem.org/cgi/content/full/jem.20051615/DC1). PCR for 
IL-4, IL-5, was performed using Sybr green I dye chemistry. Primers and 
probe sequences were as listed in Table S1. Real-Time PCR analysis was 
performed on an ABI7900 Real-Time PCR cycler (Applied Biosystems). 
Hypoxanthine phosphoribosyltransferase (HPRT) PCR was performed in 
parallel for each gene. Expression levels for each gene were quantifi  ed rela-
tive to the internal HPRT control before comparison of mRNA levels of 
each gene between the diff  erent cell populations. Expression of all other 
genes was determined using standard PCR using primers sequences as listed 
in Table S1.
Cytokine ELISA. IL-13 ELISA was performed using the Quantikine 
  Murine IL-13 Kit (R&D Systems). All other cytokine ELISAs used the 
  sandwich format with capture and detection antibodies purchased from 
  Becton Dickinson. ELISAs were performed according to Becton Dickinson 
ELISA protocol.
Mouse mast cell protease-1 ELISA. Mouse mast cell protease-1 levels in 
sera were assayed using a mouse MCP-1 ELISA kit purchased from Moredun 
Scientifi  c. ELISA was performed according to the manufacturer’s protocol.
Statistical analysis. The signifi  cance of the diff  erences between experi-
mental groups was analyzed using a Student’s unpaired Student’s t test.
Online supplemental material. Fig. S1 shows inactivation of the il25 gene 
by homologous recombination. Fig. S2 shows worm counts in lungs and in-
testines of N. brasiliensis–infected wild-type mice after treatment with rIL-25 
or control saline. Fig. S3 shows that in vitro Th1 and Th2 cell development 
is normal in cells from il25−/− mice. Table S1 shows PCR primers used in 
this study. The supplemental Materials and methods section describes gener-
ation of il25−/− mice and production of IL-25. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20051615/DC1.
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